Fig. 1 | Signal Transduction and Targeted Therapy

Fig. 1

From: Dose-escalation studies of mesenchymal stromal cell therapy for decompensated liver cirrhosis: phase Ia/Ib results and immune modulation insights

Fig. 1

Study design. a Phase Ia; b Phase Ib. scRNA-seq (single-cell RNA sequencing) profiles transcriptomes across thousands of individual cells, whereas CyTOF (cytometry by time of flight) uses metal-tagged antibodies to simultaneously quantify >40 protein markers at single-cell resolution. Integrated analysis enables cross-validation between immune cell surface protein expression and transcriptional states

Back to article page